Henan Lingrui Pharmaceutical Co., Ltd.
SHH: 600285.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wei Xiong
- Employees
- 2,530
- Headquarters
- Xinyang, China
- IPO year
- 2000
- Market cap
- CN¥12.5B
- Website
- https://www.lingrui.com
Loading 600285…
Loading profile data…Frequently asked questions about 600285
What does Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) do?
Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering approximately 100 product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomach...
Where does 600285.SS trade?
Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) trades on the Shanghai Stock Exchange.
What sector is 600285.SS in?
Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Henan Lingrui Pharmaceutical Co., Ltd.?
Wei Xiong is the chief executive officer of Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS).
Where is Henan Lingrui Pharmaceutical Co., Ltd. headquartered?
Henan Lingrui Pharmaceutical Co., Ltd. is headquartered in China.
Does 600285.SS pay a dividend?
Yes — Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) paid a trailing twelve-month dividend of CNY 0.90 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600285.SS go public?
Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) completed its initial public offering in 2000.